Cargando…
Effect of efflux pump inhibitors on the susceptibility of Mycobacterium tuberculosis to isoniazid
BACKGROUND: Mycobacterium can develop drug resistance (DR) by mutation of its existing gene. However, the existence of DR without mutation shows the need to look for an alternative mechanism such as the role of efflux pumps. In this study, we examined the effect of efflux pump inhibitors on isoniazi...
Autores principales: | Jaiswal, Indu, Jain, Amita, Verma, Sanjeev Kumar, Singh, Pooja, Kant, Surya, Singh, Mastan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5684805/ https://www.ncbi.nlm.nih.gov/pubmed/29098993 http://dx.doi.org/10.4103/0970-2113.217567 |
Ejemplares similares
-
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
por: Singhal, Parul, et al.
Publicado: (2016) -
A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014) -
Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates
por: Singh, Mradula, et al.
Publicado: (2011) -
Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis
por: Machado, Diana, et al.
Publicado: (2012) -
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
por: Lake, M. Alexandra, et al.
Publicado: (2023)